Log in to save to my catalogue

Effects of Metformin and Rosiglitazone Monotherapy on Insulin-Mediated Hepatic Glucose Uptake and Th...

Effects of Metformin and Rosiglitazone Monotherapy on Insulin-Mediated Hepatic Glucose Uptake and Th...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracgeneralonefile_A107119524

Effects of Metformin and Rosiglitazone Monotherapy on Insulin-Mediated Hepatic Glucose Uptake and Their Relation to Visceral Fat in Type 2 Diabetes

About this item

Full title

Effects of Metformin and Rosiglitazone Monotherapy on Insulin-Mediated Hepatic Glucose Uptake and Their Relation to Visceral Fat in Type 2 Diabetes

Publisher

Alexandria, VA: American Diabetes Association

Journal title

Diabetes care, 2003-07, Vol.26 (7), p.2069-2074

Language

English

Formats

Publication information

Publisher

Alexandria, VA: American Diabetes Association

More information

Scope and Contents

Contents

Effects of Metformin and Rosiglitazone Monotherapy on Insulin-Mediated Hepatic Glucose Uptake and Their Relation to Visceral
Fat in Type 2 Diabetes
Patricia Iozzo , MD 1 2 ,
Kirsti Hallsten , MD 1 ,
Vesa Oikonen , MSC 1 ,
Kirsi A. Virtanen , MD 1 ,
Riitta Parkkola , MD 3 ,
Jukka Kemppainen , MD 1 ,
Olof Solin , PHD 1 ,
Fr...

Alternative Titles

Full title

Effects of Metformin and Rosiglitazone Monotherapy on Insulin-Mediated Hepatic Glucose Uptake and Their Relation to Visceral Fat in Type 2 Diabetes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracgeneralonefile_A107119524

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracgeneralonefile_A107119524

Other Identifiers

ISSN

0149-5992

E-ISSN

1935-5548

DOI

10.2337/diacare.26.7.2069